585 related articles for article (PubMed ID: 11754710)
21. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM
Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261
[TBL] [Abstract][Full Text] [Related]
22. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
Emery P; Koncz T; Pan S; Lowry S
Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
[TBL] [Abstract][Full Text] [Related]
23. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
[TBL] [Abstract][Full Text] [Related]
24. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
Henderson P
JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939848
[No Abstract] [Full Text] [Related]
25. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
Bierma-Zeinstra SM; Bohnen AM; Berger MY; Thomas S
JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939847
[No Abstract] [Full Text] [Related]
26. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery.
Watcha MF; Issioui T; Klein KW; White PF
Anesth Analg; 2003 Apr; 96(4):987-994. PubMed ID: 12651647
[TBL] [Abstract][Full Text] [Related]
27. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
28. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Smugar SS; Schnitzer TJ; Weaver AL; Rubin BR; Polis AB; Tershakovec AM
Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
Kivitz AJ; Greenwald MW; Cohen SB; Polis AB; Najarian DK; Dixon ME; Moidel RA; Green JA; Baraf HS; Petruschke RA; Matsumoto AK; Geba GP;
J Am Geriatr Soc; 2004 May; 52(5):666-74. PubMed ID: 15086644
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
[TBL] [Abstract][Full Text] [Related]
31. Rofecoxib improves quality of life in patients with hip or knee osteoarthritis.
Theiler R; Bischoff HA; Good M; Uebelhart D
Swiss Med Wkly; 2002 Nov; 132(39-40):566-73. PubMed ID: 12571763
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.
Whelton A; Fort JG; Puma JA; Normandin D; Bello AE; Verburg KM;
Am J Ther; 2001; 8(2):85-95. PubMed ID: 11304662
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
[TBL] [Abstract][Full Text] [Related]
34. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
[TBL] [Abstract][Full Text] [Related]
35. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
Whelton A; White WB; Bello AE; Puma JA; Fort JG;
Am J Cardiol; 2002 Nov; 90(9):959-63. PubMed ID: 12398962
[TBL] [Abstract][Full Text] [Related]
36. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
37. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
[TBL] [Abstract][Full Text] [Related]
38. A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice.
Cutts C; LaCaze A; Tett S
Br J Clin Pharmacol; 2002 Nov; 54(5):522-7. PubMed ID: 12445032
[TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.
Moore PA; Hersh EV
J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
